Researchers have discovered that targeting PD-L1 recycling in myeloid cells enhances T-cell activation and boosts the effects ...
European Commission approves Merck’s Keytruda as part of a treatment regimen for adults with resectable LA-HNSCC expressing PD-L1: Rahway, New Jersey Thursday, October 30, 2025, ...
Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard ...
News Medical on MSN
Boosting First Responder Cells May Aid Cancer Therapy
Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard ...
2d
Libtayo® (cemiplimab for injection) Now Reimbursed in Québec for Advanced Non-Small Cell Lung Cancer
CNW/ - Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by Régie de l'assurance maladie du ...
Merck & Eisai announce Welireg plus Lenvima meets primary endpoint of PFS in certain previously treated patients with advanced RCC: Rahway, New Jersey Wednesday, October 29, 2025, ...
Regeneron Canada Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by public drug programs in Ontario, British Columbia, Saskatchewan, Nova Scotia, Newfoundland and ...
A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...
New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback